WBR0235: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=William J Gibson
|QuestionAuthor=William J Gibson (Reviewed by {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
Line 21: Line 21:
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Neurology, General Principles
|SubCategory=Neurology, General Principles
|Prompt=A 16 year old boy is brought to his pediatrician’s office by his father. Over the past several days she has noticed that the left side of his face has become less expressive. He reports some fatigue.  He denies any sick contacts, recent changes in mood or appetiteHe denies any recent travel, except for a camping trip with the local boy scouts approximately 2 months ago. He is sexually active with one partner.  His cardiovascular and respiratory exam is normal. His neurological exam is significant only for unilateral weakness of the facial muscles on the left side. What is the mechanism of action of the most appropriate pharmacotherapy for this patient?
|Prompt=A 19-year-old boy is brought to his pediatrician’s office by his father. Over the past several days, the patient has been increasingly fatigued and has noticed that the left side of his face has become less expressive. He denies any sick contacts or recent changes in mood, appetite, or weightThe patient also denies recent travel, except for a camping trip with the local boy scouts approximately 2 months ago. He is sexually active with one partner and uses condoms regularly. Neurological exam is significant only for unilateral weakness of the facial muscles on the left side. The physician then performs further work-up and prescribes a pharmacologic agent to treat the patient's condition. What is the mechanism of action of the prescribed pharmacologic agent?
|Explanation=The patient in this vignette is suffering from the disseminated stage of Lyme Disease.  Lyme disease is caused by the organism Borrelia Burgdorferi, a bacteria which is carried by the Ixodes tick.  In its early stages, Lyme disease causes a characteristic “bullseye” rash called erythema chronicum migrans in 80% of patients.  Most patients exhibit flu-like symptoms in the early stages of infection.  The incubation period of Lyme disease can vary greatly, but is typically 1 to 2 weeks.  If untreated, Lyme disease can cause facial palsy and AV nodal block (secondary Lyme disease) progressing to chronic monoarthritis or migratory polyarthritis (tertiary Lyme disease).  Lyme disease is treated with tetracycline antibiotics (eg doxycyline).  Tetracyclines work by blocking entry of aminoacyl tRNAs into the bacterial ribosome, thereby inhibiting protein synthesis.  
|Explanation=yme disease is a multi-organ disease that involves the skin, nervous system, the heart, and the musculoskeletal system. It is an infectious disease caused by the spirochete ''Borrelia burgdorferi'', which is transmitted to humans by ''Ixodes'' tick bite. Characteristically, tick bites are non-painful, and ticks may persist on human skin for several days. For transmission of the infection to occur, the tick needs to bite the skin for at least one day. Lyme disease is a common infection in Europe and Northeast USA during the summer and spring. The diagnosis of Lyme disease is made clinically when patients report exposure to ticks and present with typical erythema migrans on physical examination. In contrast, disseminated disease is more difficult to diagnose, and serological testing is necessary with a two-step approach: First, a high-sensitivity ELISA
|AnswerA=Activates tissue plasminogen
 
|AnswerAExp=This is the mechanism of TpA, which can be used to treat stroke or myocardial infarction.  While a stroke may produce unilateral neurologic symptoms, stroke is far less likely than lyme disease in a young patient who has recently gone on a camping trip.
Lyme disease may be classified clinically into 2 stages:
*Early Lyme disease: Characterized by erythema migrans (bull's eye lesion), which is the pathognomonic skin lesion of Lyme disease. Onset is usually between 3 and 30 days following tick bite. The most common location of erythema migrans is the lower extremities and the trunk. Patients with typical erythema migrans are generally administered empirical doxycycline with no need for further diagnostic work-up.
 
*Secondary Lyme disease: Characterized by the presence of neurological, cardiac, and rheumatic manifestations. Neurological signs may be variable and may present anytime from a few months to years following initial infection. Neurological manifestations include meningitis, encephalitis, radicular pains, flaccid palsy, and sensory abnormalities. In contrast, cardiac manifestation often appear after several weeks of initial infection. Manifestations include atrioventricular blocks, pericarditis, and rarely, pancarditis. Finally, musculoskeletal disease may develop several weeks to years after infection, and manifestations include bone and joint pain with possible edema and effusions of the large joints.
 
*Tertiary (chronic) Lyme disease: Characterized by chronic symptoms that may be present even when the organism is cleared. Manifestations may include persistent join pain and edema, chronic progressive encephalomyelitis, memory impairment, and chronic peripheral neuropathy.
 
The patient in this vignette is suffering from the disseminated stage of Lyme Disease.  Lyme disease is caused by the organism Borrelia Burgdorferi, a bacteria which is carried by the Ixodes tick.  In its early stages, Lyme disease causes a characteristic “bullseye” rash called erythema chronicum migrans in 80% of patients.  Most patients exhibit flu-like symptoms in the early stages of infection.  The incubation period of Lyme disease can vary greatly, but is typically 1 to 2 weeks.  If untreated, Lyme disease can cause facial palsy and AV nodal block (secondary Lyme disease) progressing to chronic monoarthritis or migratory polyarthritis (tertiary Lyme disease).  Lyme disease is treated with tetracycline antibiotics (eg doxycyline).  Tetracyclines work by blocking entry of aminoacyl tRNAs into the bacterial ribosome, thereby inhibiting protein synthesis.
|AnswerA=Activator of tissue plasminogen
|AnswerAExp=TpA may be indicated for specific cases of ischemic stroke or myocardial infarction (MI).  While a stroke may produce unilateral neurologic symptoms, stroke is far less likely than Lyme disease in a young patient who has recently returned from a camping trip.
|AnswerB=Nucleotide analogue
|AnswerB=Nucleotide analogue
|AnswerBExp=This is the mechanism of acyclovir, which is used to inhibit HSV replication. HSV can cause Bell’s palsy, but it is a less common cause of Bell’s palsy than Lyme disease and suspicion for Lyme disease should be elevated by the patient’s recent camping trip.
|AnswerBExp=Acyclovir is a nucleotide analogue that inhibits HSV replication. HSV can cause facial palsy, but it is a less common cause of facial palsy than Lyme disease, especially in a patient who has recently returned from a camping trip.
|AnswerC=Activates antithrombin III
|AnswerC=Activator of antithrombin III
|AnswerCExp=This is the mechanism of heparin. Heparin can be used for stoke, but stroke is far less likely than lyme disease in a young patient who has recently gone on a camping trip.
|AnswerCExp=Heparin activates antithrombin III. Heparin is indicated for thromboembolic diseases, which are less likely than Lyme disease in a young patient who has recently returned from a camping trip.
|AnswerD=Inhibits topoisomerase
|AnswerD=Inhibitor of topoisomerase
|AnswerDExp=This is the mechanism of fluoroquinolones, which are not the treatment of choice for Lyme disease.
|AnswerDExp=Fluoroquinolones are antibiotics that act by inhibiting topoisomerase activity. However, fluoroquinolones are not the optimal pharmacologic therapy to treat Lyme disease.
|AnswerE=Inhibits aminoacyl tRNA entry into ribosome
|AnswerE=Inhibitor of aminoacyl tRNA entry into ribosome
|AnswerEExp=This is the mechanism of tetracycline antibiotics which are the most appropriate pharmacotherapy for Borrelia Burgdorferi infection.
|AnswerEExp=Tetracyclines are antibiotics that act by inhibiting aminoacyl tRNA entry into ribosome. Tetracyclines are the optimal pharmacologic therapy to treat Lyme disease in adult patients.  
|EducationalObjectives=Lyme disease istreated with tetracycline antibiotics, which function by blocking entry of aminoacyl tRNAs into the bacterial ribosome, thereby inhibiting protein synthesis.
|EducationalObjectives=Tetracyclines are antibiotics that act by inhibiting aminoacyl tRNA entry into ribosome. Tetracyclines are the optimal pharmacologic therapy to treat Lyme disease in adult patients.  
|References=First Aid 2014 page 141
|References=First Aid 2014 page 141
|RightAnswer=E
|RightAnswer=E

Revision as of 17:36, 7 November 2014

 
Author [[PageAuthor::William J Gibson (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Microbiology, MainCategory::Pharmacology
Sub Category SubCategory::Neurology, SubCategory::General Principles
Prompt [[Prompt::A 19-year-old boy is brought to his pediatrician’s office by his father. Over the past several days, the patient has been increasingly fatigued and has noticed that the left side of his face has become less expressive. He denies any sick contacts or recent changes in mood, appetite, or weight. The patient also denies recent travel, except for a camping trip with the local boy scouts approximately 2 months ago. He is sexually active with one partner and uses condoms regularly. Neurological exam is significant only for unilateral weakness of the facial muscles on the left side. The physician then performs further work-up and prescribes a pharmacologic agent to treat the patient's condition. What is the mechanism of action of the prescribed pharmacologic agent?]]
Answer A AnswerA::Activator of tissue plasminogen
Answer A Explanation [[AnswerAExp::TpA may be indicated for specific cases of ischemic stroke or myocardial infarction (MI). While a stroke may produce unilateral neurologic symptoms, stroke is far less likely than Lyme disease in a young patient who has recently returned from a camping trip.]]
Answer B AnswerB::Nucleotide analogue
Answer B Explanation AnswerBExp::Acyclovir is a nucleotide analogue that inhibits HSV replication. HSV can cause facial palsy, but it is a less common cause of facial palsy than Lyme disease, especially in a patient who has recently returned from a camping trip.
Answer C AnswerC::Activator of antithrombin III
Answer C Explanation AnswerCExp::Heparin activates antithrombin III. Heparin is indicated for thromboembolic diseases, which are less likely than Lyme disease in a young patient who has recently returned from a camping trip.
Answer D AnswerD::Inhibitor of topoisomerase
Answer D Explanation AnswerDExp::Fluoroquinolones are antibiotics that act by inhibiting topoisomerase activity. However, fluoroquinolones are not the optimal pharmacologic therapy to treat Lyme disease.
Answer E AnswerE::Inhibitor of aminoacyl tRNA entry into ribosome
Answer E Explanation AnswerEExp::Tetracyclines are antibiotics that act by inhibiting aminoacyl tRNA entry into ribosome. Tetracyclines are the optimal pharmacologic therapy to treat Lyme disease in adult patients.
Right Answer RightAnswer::E
Explanation [[Explanation::yme disease is a multi-organ disease that involves the skin, nervous system, the heart, and the musculoskeletal system. It is an infectious disease caused by the spirochete Borrelia burgdorferi, which is transmitted to humans by Ixodes tick bite. Characteristically, tick bites are non-painful, and ticks may persist on human skin for several days. For transmission of the infection to occur, the tick needs to bite the skin for at least one day. Lyme disease is a common infection in Europe and Northeast USA during the summer and spring. The diagnosis of Lyme disease is made clinically when patients report exposure to ticks and present with typical erythema migrans on physical examination. In contrast, disseminated disease is more difficult to diagnose, and serological testing is necessary with a two-step approach: First, a high-sensitivity ELISA

Lyme disease may be classified clinically into 2 stages:

  • Early Lyme disease: Characterized by erythema migrans (bull's eye lesion), which is the pathognomonic skin lesion of Lyme disease. Onset is usually between 3 and 30 days following tick bite. The most common location of erythema migrans is the lower extremities and the trunk. Patients with typical erythema migrans are generally administered empirical doxycycline with no need for further diagnostic work-up.
  • Secondary Lyme disease: Characterized by the presence of neurological, cardiac, and rheumatic manifestations. Neurological signs may be variable and may present anytime from a few months to years following initial infection. Neurological manifestations include meningitis, encephalitis, radicular pains, flaccid palsy, and sensory abnormalities. In contrast, cardiac manifestation often appear after several weeks of initial infection. Manifestations include atrioventricular blocks, pericarditis, and rarely, pancarditis. Finally, musculoskeletal disease may develop several weeks to years after infection, and manifestations include bone and joint pain with possible edema and effusions of the large joints.
  • Tertiary (chronic) Lyme disease: Characterized by chronic symptoms that may be present even when the organism is cleared. Manifestations may include persistent join pain and edema, chronic progressive encephalomyelitis, memory impairment, and chronic peripheral neuropathy.

The patient in this vignette is suffering from the disseminated stage of Lyme Disease. Lyme disease is caused by the organism Borrelia Burgdorferi, a bacteria which is carried by the Ixodes tick. In its early stages, Lyme disease causes a characteristic “bullseye” rash called erythema chronicum migrans in 80% of patients. Most patients exhibit flu-like symptoms in the early stages of infection. The incubation period of Lyme disease can vary greatly, but is typically 1 to 2 weeks. If untreated, Lyme disease can cause facial palsy and AV nodal block (secondary Lyme disease) progressing to chronic monoarthritis or migratory polyarthritis (tertiary Lyme disease). Lyme disease is treated with tetracycline antibiotics (eg doxycyline). Tetracyclines work by blocking entry of aminoacyl tRNAs into the bacterial ribosome, thereby inhibiting protein synthesis.
Educational Objective: Tetracyclines are antibiotics that act by inhibiting aminoacyl tRNA entry into ribosome. Tetracyclines are the optimal pharmacologic therapy to treat Lyme disease in adult patients.
References: First Aid 2014 page 141]]

Approved Approved::Yes
Keyword WBRKeyword::Lyme disease, WBRKeyword::Lyme, WBRKeyword::Borrelia Burgdorferi, WBRKeyword::Microbiology, WBRKeyword::Gram negative, WBRKeyword::Gram-negative, WBRKeyword::Bacteria, WBRKeyword::Zoonotic, WBRKeyword::Antibiotic, WBRKeyword::Antibiotics
Linked Question Linked::
Order in Linked Questions LinkedOrder::